| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $568.95 ▲ +0.89% | Yesterday | $566.80 ▼ -0.51% | Tomorrow's United Therapeutics Corporation Common Stock (UTHR) setup is anchored to $563.93 and targets $568.95 (+0.89%). The near-term read is upside; watch $572.12 / $560.16 because daily realized volatility is about 1.51%. |
Tomorrow's United Therapeutics Corporation Common Stock (UTHR) setup is anchored to $563.93 and targets $568.95 (+0.89%). The near-term read is upside; watch $572.12 / $560.16 because daily realized volatility is about 1.51%. | ||||
| Week | $561.00 ▼ -0.52% | Last Week | $575.79 ▼ -2.06% | The 7-day United Therapeutics Corporation Common Stock model moves from $575.79 to $561.00 (-0.52%). It gives downside momentum context for this stock, so breaks around $572.12 / $560.16 matter more than a single tick. |
The 7-day United Therapeutics Corporation Common Stock model moves from $575.79 to $561.00 (-0.52%). It gives downside momentum context for this stock, so breaks around $572.12 / $560.16 matter more than a single tick. | ||||
| Month | $547.14 ▼ -2.98% | Last Month | $573.46 ▼ -1.66% | The 1-month United Therapeutics Corporation Common Stock target is $547.14 (-2.98%), compared with the live reference near $563.93. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month United Therapeutics Corporation Common Stock target is $547.14 (-2.98%), compared with the live reference near $563.93. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $526.57 ▼ -6.62% | Last Year | $309.68 ▲ +82.10% | The 1-year United Therapeutics Corporation Common Stock scenario points to $526.57 (-6.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year United Therapeutics Corporation Common Stock scenario points to $526.57 (-6.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $478.89 ▼ -15.08% | 5 Years Ago | $188.72 ▲ +198.82% | The 5-year United Therapeutics Corporation Common Stock view is $478.89 (-15.08%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year United Therapeutics Corporation Common Stock view is $478.89 (-15.08%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| RSI 14 | 92.2 | Bullish |
| MACD | 0.02 | Neutral |
| SMA 50 | $564.53 | Mid |
| SMA 200 | $495.45 | Above |
| EMA 20 | $488.94 | Above |
| Opening Price | $570.37 | Start Date | 2020-01-02 |
| Day Range | $560.89 – $578.60 | Market Cap | $25.13B |
| Monthly Range | $563.93 – $596.76 | 24h Volume | n/a |
| 90D Range | $464.93 – $596.76 | Circulating | n/a |
| 52W Range | $274.70 – $596.76 | Max Supply | n/a |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.